Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis.
Greco G, Risi M, Masciocchi S, Businaro P, Rigoni E, Zardini E, Scaranzin S, Morandi C, Diamanti L, Foiadelli T, Giannoccaro MP, Morelli L, Liguori R, Barone P, Tozzo A, Passarini A, Gelibter S, Patti F, Banfi P, Simone AM, Bisecco A, Ruggieri M, Maimone D, Bruno G, Siliquini S, Bova S, Di Filippo M, Lanzillo R, Gallo A, Colombo E, Franciotta D, Gastaldi M; Neuroimmunology Platform (PNI) study group. Greco G, et al. J Neurol Neurosurg Psychiatry. 2024 Jun 6:jnnp-2024-333554. doi: 10.1136/jnnp-2024-333554. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 38844341
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab.
Signoriello E, Signori A, Lus G, Romano G, Marfia GA, Landi D, Napoli F, D' Amico E, Zanghí A, Di Filippo PS, Caliendo D, Carotenuto A, Spiezia AL, Fantozzi R, Centonze D, Lucchini M, Mirabella M, Cocco E, Frau J, Maniscalco GT, Di Battista ME, Foschi M, Surcinelli A, Bonavita S, Abbadessa G, Pasquali L, Di Gregorio M, Ferrò MT, Sormani MP, Schiavetti I; ON focus study group. Signoriello E, et al. Among authors: spiezia al. Mult Scler Relat Disord. 2024 Jul;87:105594. doi: 10.1016/j.msard.2024.105594. Epub 2024 Apr 6. Mult Scler Relat Disord. 2024. PMID: 38718748 Free article.
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.
Maida E, Moccia M, Palladino R, Borriello G, Affinito G, Clerico M, Repice AM, Di Sapio A, Iodice R, Spiezia AL, Sparaco M, Miele G, Bile F, Scandurra C, Ferraro D, Stromillo ML, Docimo R, De Martino A, Mancinelli L, Abbadessa G, Smolik K, Lorusso L, Leone M, Leveraro E, Lauro F, Trojsi F, Streito LM, Gabriele F, Marinelli F, Ianniello A, De Santis F, Foschi M, De Stefano N, Morra VB, Bisecco A, Coghe G, Cocco E, Romoli M, Corea F, Leocani L, Frau J, Sacco S, Inglese M, Carotenuto A, Lanzillo R, Padovani A, Triassi M, Bonavita S, Lavorgna L; Digital Technologies, Web, Social Media Study Group of the Italian Society of Neurology (SIN). Maida E, et al. Among authors: spiezia al. J Neurol. 2024 Apr 3. doi: 10.1007/s00415-024-12328-x. Online ahead of print. J Neurol. 2024. PMID: 38568227
Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis.
Novarella F, Carotenuto A, Cipullo P, Iodice R, Cassano E, Spiezia AL, Capasso N, Petracca M, Falco F, Iacovazzo C, Servillo G, Lanzillo R, Brescia Morra V, Moccia M. Novarella F, et al. Among authors: spiezia al. Toxins (Basel). 2022 Nov 9;14(11):774. doi: 10.3390/toxins14110774. Toxins (Basel). 2022. PMID: 36356024 Free PMC article.
Quality of Life Changes in Early-Onset Multiple Sclerosis: A 4-Year Follow-Up Study.
Rosa L, Petracca M, Carotenuto A, Dolce P, Piscopo K, Dicé F, Lauro F, Spiezia AL, Moccia M, Lavorgna L, Iacovazzo C, Servillo G, Maldonato NM, Chiodi A, Brescia Morra V, Lanzillo R. Rosa L, et al. Among authors: spiezia al. J Clin Med. 2022 Sep 4;11(17):5226. doi: 10.3390/jcm11175226. J Clin Med. 2022. PMID: 36079156 Free PMC article.
18 results